Pages that link to "Q37040481"
Jump to navigation
Jump to search
The following pages link to IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients (Q37040481):
Displaying 10 items.
- Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells. (Q27307719) (← links)
- Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma (Q28071998) (← links)
- Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity (Q35940189) (← links)
- Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma (Q37692604) (← links)
- Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer. (Q51063063) (← links)
- Serum cytokine profile of laryngeal squamous cell carcinoma patients. (Q51098902) (← links)
- Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen. (Q55293126) (← links)
- IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers. (Q55515909) (← links)
- Immunotherapy for Head and Neck Squamous Cell Carcinoma (Q87861147) (← links)
- Impairment of NKG2D-Mediated Tumor Immunity by TGF-β (Q91708036) (← links)